Co-Authors
This is a "connection" page, showing publications co-authored by PATRICK CHAFTARI and GEORGE KYPRIOTAKIS.
Connection Strength
0.091
-
Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center. Am J Addict. 2022 05; 31(3):236-241.
Score: 0.052
-
Improvement of Smoking Abstinence Rates With Increased Varenicline Dosage: A Propensity Score-Matched Analysis. J Clin Psychopharmacol. 2018 Feb; 38(1):34-41.
Score: 0.039